. . "Glycopeptide dendrimers. Part II"@en . . "Glycopeptide dendrimers. Part II"@en . . "Glycopeptide dendrimers. Part II" . "3"^^ . "Niederhafner, Petr" . . . . . . . "3"^^ . "1075-2617" . "P(GA203/03/1362), P(GA203/06/1272), P(KAN200520703), P(QF3115), Z(AV0Z40550506)" . "Glykopeptidov\u00E9 dendrimery. \u010C\u00E1st II"@cs . . "Je\u017Eek, Jan" . . . . "Journal of Peptide Science" . "Review Glykopeptidov\u00E9 dendrimery, \u010C\u00E1st II (pro \u010C\u00E1st I viz. Je\u017Eek J., et al., J. Pept. Sci. 2008; 14: 2-43) se zab\u00FDv\u00E1 line\u00E1rn\u00EDmi oligomery s variabiln\u00ED valenc\u00ED (brush dendrimery, comb dendrimery), sekven\u010Dn\u00ED oligopeptidov\u00E9 nosi\u010De SOCn-I and SOCn-II, chitosan obsahuj\u00EDc\u00ED dendrimery a brush dendrimery. Jin\u00E9 typy glykopeptidov\u00FDch dendrimer\u016F jsou kask\u00E1dov\u00E9 dendrimery a domino dendrimery. Pops\u00E1ny jsou t\u00E9\u017E knihovny glykopeptidov\u00FDch dendrimer\u016F. Charakterizace glykopeptidov\u00FDch dendrimer\u016F, jejich chiralita, stabilita, biokompatibilita, toxicita a biomedic\u00EDnsk\u00E9 aplikace (zobrazuj\u00EDc\u00ED a kontrastn\u00ED l\u00E1tky, transportn\u00ED syst\u00E9my pro l\u00E9\u010Diva, artifici\u00E1ln\u00ED viry, syntetick\u00E9 antivir\u00E1ln\u00ED, antibakteri\u00E1ln\u00ED a protin\u00E1dorov\u00E9 vakc\u00EDny) jsou diskutov\u00E1ny s uveden\u00EDm mnoha p\u0159\u00EDklad\u016F."@cs . "14" . "Glykopeptidov\u00E9 dendrimery. \u010C\u00E1st II"@cs . . "artificial virus; cascade-release dendrimers; glycopeptide dendrimers; glycoconjugate; glycopeptides"@en . . . "RIV/61388963:_____/08:00306043!RIV08-AV0-61388963" . . . "44;65" . . . "369510" . "Glycopeptide dendrimers, Part II (for Part I see Jezek J, et al., J. Pept. Sci. 2008; 14: 2-43) covers linear oligomers with variable valency (brush dendrimers, comb dendrimers), sequential oligopeptide carriers SOCn-I and SOCn-II, chitosan-based dendrimers, and brush dendrimers. Other types of glycopeptide dendrimers are self-imolative dendrimers (cascade release dendrimers, domino dendrimers). Libraries of glycopeptide dendrimers are also included. Characterization of glycopeptide dendrimers, their chirality, stability, biocompatibility, toxicity and biomedical applications (imaging and contrast agents, drug delivery systems, artificial viruses, synthetic antiviral, antibacterial and anticancer vaccines etc.) are given with many examples." . . . "Glycopeptide dendrimers. Part II" . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "\u0160ebest\u00EDk, Jaroslav" . "22"^^ . "[8C142FB6866E]" . "Glycopeptide dendrimers, Part II (for Part I see Jezek J, et al., J. Pept. Sci. 2008; 14: 2-43) covers linear oligomers with variable valency (brush dendrimers, comb dendrimers), sequential oligopeptide carriers SOCn-I and SOCn-II, chitosan-based dendrimers, and brush dendrimers. Other types of glycopeptide dendrimers are self-imolative dendrimers (cascade release dendrimers, domino dendrimers). Libraries of glycopeptide dendrimers are also included. Characterization of glycopeptide dendrimers, their chirality, stability, biocompatibility, toxicity and biomedical applications (imaging and contrast agents, drug delivery systems, artificial viruses, synthetic antiviral, antibacterial and anticancer vaccines etc.) are given with many examples."@en . "1" . "RIV/61388963:_____/08:00306043" .